rs60314569

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000424.4(KRT5):​c.556-15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 1,613,858 control chromosomes in the GnomAD database, including 15,698 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2135 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13563 hom. )

Consequence

KRT5
NM_000424.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.384

Publications

5 publications found
Variant links:
Genes affected
KRT5 (HGNC:6442): (keratin 5) The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Jul 2008]
KRT5 Gene-Disease associations (from GenCC):
  • Dowling-Degos disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • epidermolysis bullosa simplex 1A, generalized severe
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics
  • epidermolysis bullosa simplex 2F, with mottled pigmentation
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia, G2P
  • Dowling-Degos disease 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • epidermolysis bullosa simplex 1B, generalized intermediate
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • epidermolysis bullosa simplex 1C, localized
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • epidermolysis bullosa simplex 2B, generalized intermediate
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epidermolysis bullosa simplex 2E, with migratory circinate erythema
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-52519175-G-A is Benign according to our data. Variant chr12-52519175-G-A is described in ClinVar as Benign. ClinVar VariationId is 256044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.213 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRT5NM_000424.4 linkc.556-15C>T intron_variant Intron 1 of 8 ENST00000252242.9 NP_000415.2 P13647

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRT5ENST00000252242.9 linkc.556-15C>T intron_variant Intron 1 of 8 1 NM_000424.4 ENSP00000252242.4 P13647

Frequencies

GnomAD3 genomes
AF:
0.161
AC:
24453
AN:
152048
Hom.:
2128
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.216
Gnomad AMI
AF:
0.270
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.198
Gnomad EAS
AF:
0.0336
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.138
Gnomad OTH
AF:
0.188
GnomAD2 exomes
AF:
0.135
AC:
33891
AN:
251080
AF XY:
0.133
show subpopulations
Gnomad AFR exome
AF:
0.220
Gnomad AMR exome
AF:
0.152
Gnomad ASJ exome
AF:
0.204
Gnomad EAS exome
AF:
0.0303
Gnomad FIN exome
AF:
0.129
Gnomad NFE exome
AF:
0.137
Gnomad OTH exome
AF:
0.146
GnomAD4 exome
AF:
0.132
AC:
193020
AN:
1461692
Hom.:
13563
Cov.:
37
AF XY:
0.131
AC XY:
95309
AN XY:
727158
show subpopulations
African (AFR)
AF:
0.220
AC:
7351
AN:
33470
American (AMR)
AF:
0.156
AC:
6954
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.199
AC:
5194
AN:
26136
East Asian (EAS)
AF:
0.0247
AC:
979
AN:
39700
South Asian (SAS)
AF:
0.103
AC:
8873
AN:
86254
European-Finnish (FIN)
AF:
0.132
AC:
7067
AN:
53412
Middle Eastern (MID)
AF:
0.191
AC:
1087
AN:
5702
European-Non Finnish (NFE)
AF:
0.132
AC:
147084
AN:
1111948
Other (OTH)
AF:
0.140
AC:
8431
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
9622
19243
28865
38486
48108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5276
10552
15828
21104
26380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.161
AC:
24491
AN:
152166
Hom.:
2135
Cov.:
32
AF XY:
0.161
AC XY:
11970
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.216
AC:
8978
AN:
41508
American (AMR)
AF:
0.181
AC:
2767
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.198
AC:
686
AN:
3470
East Asian (EAS)
AF:
0.0333
AC:
172
AN:
5170
South Asian (SAS)
AF:
0.103
AC:
496
AN:
4818
European-Finnish (FIN)
AF:
0.126
AC:
1331
AN:
10598
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.138
AC:
9362
AN:
67984
Other (OTH)
AF:
0.185
AC:
391
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1029
2058
3087
4116
5145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
204
Bravo
AF:
0.166
Asia WGS
AF:
0.0910
AC:
318
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epidermolysis bullosa simplex Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
3.4
DANN
Benign
0.69
PhyloP100
0.38
PromoterAI
-0.0010
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60314569; hg19: chr12-52912959; COSMIC: COSV107254097; COSMIC: COSV107254097; API